Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Trey Thoelcke | Nov 16, 2024 at 9:10 AM EST

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady…

Chris MacDonald | Nov 1, 2024 at 8:11 AM EDT

Here Are the Next 3 Stock Splits to Keep on Your Radar

A stock split divides existing shares into multiple new ones, increasing a given company’s share count and making shares more…

John Seetoo | Oct 29, 2024 at 9:15 AM EDT

Need $450 a Month in Passive Income? Invest $5K Each in These 9 Funds

It’s no surprise that inflation over the past four years have sent the prices of goods and services steeply spiraling…

Rich Duprey | Oct 25, 2024 at 11:03 AM EDT

2 Terrific Growth ETFs to Buy Before 2025 That Aren’t Schwab US Dividend ETF

There is a reason the Schwab US Dividend ETF (NYSEARCA:SCHD | SCHD Price Prediction) is a top-of-list purchase for investors.…

Kristin Hitchcock | Oct 6, 2024 at 12:32 PM EDT

VUG vs. VOO: Which ETF Should You Buy?

In the ever-changing world of investing, ETFs have become the go-to choice for many novice and seasoned investors. ETFs are…

Trey Thoelcke | Oct 4, 2024 at 9:15 AM EDT

Prediction: This Will Be the Best-Performing Stock in 2030

Selecting stocks for the long haul can be a challenge. Here is what could be the best-performing stock in 2030…

Chris MacDonald | Oct 3, 2024 at 8:11 AM EDT

3 Top Pharma Stocks to Buy in October 2024

The pharmaceutical industry plays a crucial role in most of our everyday lives. From life-saving medication we need when we…

Kristin Hitchcock | Sep 30, 2024 at 10:49 AM EDT

VTI vs. VOO: Which ETF Should You Buy?

Diversification is key in today’s investing world. Exchange-traded funds, or ETFs, offer a convenient and affordable way to achieve this.…

Kristin Hitchcock | Sep 26, 2024 at 8:42 AM EDT

QQQ vs. VOO: Which ETF Should You Buy?

247 Wall St. Key Insights QQQ offers higher growth potential but comes with greater risk due to its reliance on…

Chris MacDonald | Sep 23, 2024 at 8:52 AM EDT

The 3 Top Pharma Stocks to Buy in September 2024

Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized…

Trey Thoelcke | Sep 19, 2024 at 9:15 AM EDT

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Eli Lilly is the clear frontrunner to be the largest pharmaceutical stock in 2034. See what the company's prospects are…

Rich Duprey | Sep 14, 2024 at 11:42 AM EDT

Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell

Jim Cramer is probably the closest thing we have to stock market superstar influencer. The host of CNBC’s “Mad Money”…

Ian Cooper | Sep 12, 2024 at 11:50 AM EDT

Five Top Obesity Stocks to Buy and Hold Long Term

Some of the best opportunities can still be found in obesity treatment stocks. Look at Viking Therapeutics (NASDAQ:VKTX | VKTX…

Joey Frenette | Sep 11, 2024 at 2:40 PM EDT

2 Weight Loss Drug Stocks Worth Stashing Away for Years

As the high-growth trade fizzles out in September, even some top-tier secular growth plays will take an outsized hit to…

Rich Duprey | Sep 8, 2024 at 12:32 PM EDT

2 Biotech Bets to Buy in September

Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or…

1 … 6 7 8 9 10 … 42

Eli Lilly : LLY

All Eli Lilly Articles

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

Here Are the Next 3 Stock Splits to Keep on Your Radar

Need $450 a Month in Passive Income? Invest $5K Each in These 9 Funds

2 Terrific Growth ETFs to Buy Before 2025 That Aren’t Schwab US Dividend ETF

VUG vs. VOO: Which ETF Should You Buy?

Prediction: This Will Be the Best-Performing Stock in 2030

3 Top Pharma Stocks to Buy in October 2024

VTI vs. VOO: Which ETF Should You Buy?

QQQ vs. VOO: Which ETF Should You Buy?

The 3 Top Pharma Stocks to Buy in September 2024

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell

Five Top Obesity Stocks to Buy and Hold Long Term

2 Weight Loss Drug Stocks Worth Stashing Away for Years

2 Biotech Bets to Buy in September

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

Eli Lilly : LLY

All Eli Lilly Articles

Dividend King AbbVie Just Paid Investors: Here’s How Much They Got

Here Are the Next 3 Stock Splits to Keep on Your Radar

Need $450 a Month in Passive Income? Invest $5K Each in These 9 Funds

2 Terrific Growth ETFs to Buy Before 2025 That Aren’t Schwab US Dividend ETF

VUG vs. VOO: Which ETF Should You Buy?

Prediction: This Will Be the Best-Performing Stock in 2030

3 Top Pharma Stocks to Buy in October 2024

VTI vs. VOO: Which ETF Should You Buy?

QQQ vs. VOO: Which ETF Should You Buy?

The 3 Top Pharma Stocks to Buy in September 2024

Prediction: This Will Be the Biggest Pharma Stock in 10 Years

Not So Fast Jim Cramer, You Should Buy These 3 Stocks He Says to Sell

Five Top Obesity Stocks to Buy and Hold Long Term

2 Weight Loss Drug Stocks Worth Stashing Away for Years

2 Biotech Bets to Buy in September

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s